Cancer procoagulant (CP) in surgical oncology diagnostics
Journal Title: Współczesna Onkologia - Year 2005, Vol 9, Issue 10
Abstract
A considerable advancement of the neoplastic process at the start of the treatment is one of the major reasons of high mortality caused by malignant neoplasms. Numerous studies have been devoted to the diagnosis of cancer at its earliest stage, as the earliest administration of treatment tremendously increases chances of patients for total recovery. A considerable progress in oncological diagnostics has been observed since 1846, when the protein test of Bence-Jones was used in the diagnostics of multiple myeloma, for the first time. In the following decades, neoplastic markers were isolated and described. Since the discovery of carcinoembryonal antigen (CEA) and alpha – fetoprotein (AFP), which appeared to be a breakthrough in the research of neoplastic markers, determination of neoplastic markers has been introduced to the routine oncological diagnostics. At present, neoplastic markers, next to clinical examination and scanning (ultrasound, computed tomography, and magnetic resonance imaging) play an important role in detecting and monitoring malignant neoplasms. A significant increase of CP activity in the serum (in comparison to healthy persons) was found in many cancers of the gastrointestinal tract (oesophagus, stomach, liver, pancreas, colon) and the thyroid. The results of our own and other studies, show that examination of the CP activity could be used as a marker in oncological diagnostics.
Authors and Affiliations
Sławomir Szajda, Jadwiga Snarska, Zdzisław Skrzydlewski, Krzysztof Zwierz
Keywords
Related Articles
- EP ID EP107375
- DOI -
- Views 54
- Downloads 0
Czwarte międzynarodowe sympozjum nt. celowanego leczenia przeciwnowotworowego – sprawozdanie
Rak jelita grubego w świetle współczesnych badań molekularnych
Populacja ludzi dotknięta rakiem jelita grubego to mieszkańcy państw wysoko uprzemysłowionych. Rocznie stwierdza się 875 tys. nowych przypadków tej choroby, a umiera 570 tys. osób. Ogromna większość chorych to przypadki...
c-myc oncogene aberration in breast cancer patients assessed by direct double differential PCR
Breast cancer is the most frequent tumour diagnosed in women, especially in well-developed countries. One of the genes of the highest interest in its diagnosis and prognosis is protooncogene c-myc, which plays a role as...
Surgical treatment of colorectal cancer liver metastases
Pierwotny gruczolakorak wyrostka robaczkowego – opis przypadku
Pierwotny gruczolakorak wyrostka robaczkowego jest bardzo rzadkim nowotworem. W literaturze opisano mniej niż 250 przypadków. W artykule przedstawiono przypadek 48-letniej kobiety z objawami ostrego zapalenia wyrostka ro...